Literature DB >> 4590096

Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.

S F Cardos, A L Florman, M S Simberkoff, L Lanier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4590096

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

1.  Tween 80 medium for differentiating nonpigmented Serratia from other Enterobacteriaceae.

Authors:  D J Lovell; D J Bibel
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

2.  The increasing isolation of Serratia species from clinical specimens.

Authors:  H J Brooks; T J Chambers; S Tabaqchali
Journal:  J Hyg (Lond)       Date:  1979-02

3.  Combined serotyping and biotyping of Serratia marcescens.

Authors:  S J Rubin; S Brock; M Chamberland; R W Lyons
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

4.  Antibody response to Serratia marcescens isolated from patients with malignant diseases.

Authors:  E K Griffiths; M J Surgalla; J E Fitzpatrick; E Neter
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

5.  Nosocomial transmission of Serratia marcescens in a veterinary hospital due to contamination by benzalkonium chloride.

Authors:  J G Fox; C M Beaucage; C A Folta; G W Thornton
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

Review 6.  Pain Therapy Guided by Purpose and Perspective in Light of the Opioid Epidemic.

Authors:  Amie L Severino; Arash Shadfar; Joshua K Hakimian; Oliver Crane; Ganeev Singh; Keith Heinzerling; Wendy M Walwyn
Journal:  Front Psychiatry       Date:  2018-04-23       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.